IRIS
CASTELLI, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 128
NA - Nord America 105
AS - Asia 49
AF - Africa 7
Totale 289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 105
IT - Italia 65
IE - Irlanda 24
FR - Francia 13
JP - Giappone 9
BD - Bangladesh 8
ET - Etiopia 7
DE - Germania 6
TR - Turchia 5
CZ - Repubblica Ceca 4
ES - Italia 4
IN - India 4
IR - Iran 4
SG - Singapore 4
FI - Finlandia 3
GB - Regno Unito 3
NL - Olanda 3
TH - Thailandia 3
VN - Vietnam 3
CN - Cina 2
KR - Corea 2
OM - Oman 2
PL - Polonia 2
TW - Taiwan 2
CY - Cipro 1
RU - Federazione Russa 1
Totale 289
Salva come PNG Salva come JPEG
Città #
Clarks Summit 40
Dublin 24
Parma 20
Kansas City 16
New York 6
Ashburn 5
Redmond 5
Casina 4
Dorchester 4
Higashifukai 4
Reggio Nell'emilia 4
Tappahannock 4
Council Bluffs 3
Grandate 3
Helsinki 3
Singapore 3
Tehran 3
Amsterdam 2
Antalya 2
Chachoengsao 2
Gijón 2
Hanoi 2
Lake Forest 2
London 2
Muscat 2
Nakayamadai 2
Naples 2
Noceto 2
Rimini 2
Roswell 2
San Genesio Ed Uniti 2
Seville 2
Shanghai 2
Taipei 2
Traversetolo 2
Akola 1
Bedford 1
Boardman 1
Bologna 1
Boydton 1
Bremen 1
Brighton 1
Caen 1
Chennai 1
Chicago 1
Dong Ket 1
Düsseldorf 1
Fars 1
Fort Lauderdale 1
Kirkland 1
Los Angeles 1
Mcallen 1
Monza 1
Mumbai 1
Nanuet 1
Nicosia 1
Owings Mills 1
Piacenza 1
Pleasantville 1
Ponte Lambro 1
Reggio Emilia 1
Rocca Canavese 1
Rottofreno 1
Shreveport 1
Songkhla 1
Tokyo 1
Verona 1
Totale 219
Salva come PNG Salva come JPEG
Nome #
Hierarchical Self-Assembly of Luminescent Eu(III) Complexes on Silicon, file e177fbc4-423d-50b0-e053-d805fe0adaee 65
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system, file e177fbc5-0615-50b0-e053-d805fe0adaee 62
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids, file e177fbc7-cf6d-50b0-e053-d805fe0adaee 35
Fighting tertiary mutations in EGFR-driven lung-cancers: Current advances and future perspectives in medicinal chemistry, file e177fbc7-9d62-50b0-e053-d805fe0adaee 33
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor, file e177fbc7-500b-50b0-e053-d805fe0adaee 25
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling, file e177fbc7-888f-50b0-e053-d805fe0adaee 18
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines., file e177fbc6-8938-50b0-e053-d805fe0adaee 14
Fatty acid amide hydrolase inhibitors: a patent review (2009 - 2014), file e177fbc7-5175-50b0-e053-d805fe0adaee 6
Fighting tertiary mutations in EGFR-driven lung-cancers: Current advances and future perspectives in medicinal chemistry, file e177fbc7-2765-50b0-e053-d805fe0adaee 5
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties, file e177fbc7-9ebc-50b0-e053-d805fe0adaee 5
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice, file e177fbc6-2dfe-50b0-e053-d805fe0adaee 3
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors, file 64aaf389-c974-40b2-9d3c-0c0b4144998c 2
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction, file e177fbc4-a2da-50b0-e053-d805fe0adaee 2
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity., file e177fbc4-a82e-50b0-e053-d805fe0adaee 2
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine, file e177fbc7-9c8b-50b0-e053-d805fe0adaee 2
Evaluation of the anti-tumor activity of small molecules targeting eph/ephrins in apcmin j mice, file e177fbc7-ab1a-50b0-e053-d805fe0adaee 2
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein–Protein Antagonists, file e177fbc4-3b43-50b0-e053-d805fe0adaee 1
Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor., file e177fbc4-3cbb-50b0-e053-d805fe0adaee 1
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin, file e177fbc7-6e72-50b0-e053-d805fe0adaee 1
FGF trapping inhibits multiple myeloma growth through c-Myc degradation–induced mitochondrial oxidative stress, file e177fbc7-7404-50b0-e053-d805fe0adaee 1
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties, file e177fbc7-9809-50b0-e053-d805fe0adaee 1
Fibroblast growth factor receptor inhibitors: patent review (2015–2019), file e177fbc7-a59a-50b0-e053-d805fe0adaee 1
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines, file e177fbc7-a889-50b0-e053-d805fe0adaee 1
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR, file e177fbc7-ab25-50b0-e053-d805fe0adaee 1
Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in mice, file e177fbc7-afda-50b0-e053-d805fe0adaee 1
Totale 290
Salva come PNG Salva come JPEG
Categoria #
all - tutte 770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 1 0 0 0 0 0 0 0 0 0 0
2020/20213 0 0 0 0 0 1 0 0 1 0 0 1
2021/202250 0 1 0 4 0 1 26 2 6 4 3 3
2022/2023143 11 11 8 10 10 6 24 9 34 8 9 3
2023/202421 4 3 3 0 0 0 5 4 2 0 0 0
Totale 290